Changing Lifestyle Preferences is propelling the Growth of the Self-injection Devices Market in the APAC Region!
- Himanshu Patni
- July 13, 2023
- HEALTHCARE, NEWS
- Self-injection Devices Market, Self-injection Devices Market size, Self-injection Devices Marketgrowth, Self-injection Devices Marketshare, Self-injection Devices Markettrends
- 0 Comments
The Asia Pacific is home to a large patient population as the region consists of countries such as China, India, Japan, Malaysia, Indonesia, and among others. The changing lifestyle preferences, along with the increasing lifestyle-related diseases like diabetes and obesity in the region are important attributing factors for the market growth of self-injection devices. For instance, as per the WHO, In India, there are estimated 77 million people above the age of 18 years are suffering from diabetes (type 2) and nearly 25 million are prediabetics (at a higher risk of developing diabetes in near future). In addition, there is a trend toward the development of more user-friendly and technologically advanced self-injection devices, such as smart pens and wearable devices. These devices offer greater convenience and, and are expected to further drive growth in the market.
Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=38549
Further, the Asia-Pacific Self-Injection Devices Market is expected to grow at a strong CAGR of 6% during the forecast period (2022-2028). The geriatric population in the region is becoming a major concern for healthcare facilities in dealing with the rising number of patients and hospitalization cases, resulting in the increasing demand for injectables. Further, the market players are also launching their products in the market also becomes an important factor in the growth of the market in Asia-Pacific.
FIG. 1 APAC Self-injection Devices Market Revenue (2020-2028)- USD Mn
For a detailed analysis of the Global Self-injection devices Market browse through – https://univdatos.com/report/self-injection-devices-market/
Based on product, the market is segmented into autoinjectors, pen injectors, wearable injectors, and needle-free injectors. Pen injectors held dominating share in 2021. Pen injectors are medical devices that are used to deliver medication subcutaneously (under the skin) or intramuscularly (into the muscle). They consist of a pen-like device that contains a pre-filled cartridge or a replaceable insulin reservoir, and a needle that is attached to the end of the pen. The convenient usage of the self-injection of these devices, along with the increasing prevalence of chronic diseases, is attributed to the growth of the segment.
On the basis of usability, the market is bifurcated into disposable and reusable. The disposable segment held a significant share of the self-injection devices market in 2021. This is mainly due to the disposable self-injection devices being sterile and designed for single use, which reduces the risk of infection or contamination. This is particularly important for patients who have compromised immune systems or are at higher risk for infection.
Based on application, the market is segmented into cancer, autoimmune disorders, hormonal disorders, pain management, and others. The cancer had the largest share in 2021 in the self-injection devices market. The higher prevalence of cancer is responsible for the increasing demand for self-injection devices. For instance, as per the National Cancer Institute, in 2020, an estimated 1,806,590 new cases of cancer will be diagnosed in the United States and 606,520 people will die from the disease.
Global Self-Injection Devices Market Segmentation
Market Insight, by Product
· Autoinjectors
· Pen injectors
· Wearable injectors
· Needle-free injectors
Market Insight, by Usability
· Disposable
· Reusable
Market Insights, by Application
· Cancer
· Autoimmune disorders
· Hormonal disorders
· Pain management
· Others
Market Insight, by Region
· North America
o U.S.
o Canada
o Rest of North America
· Europe
o Germany
o UK
o Netherlands
o France
o Norway
o Switzerland
o Denmark
o Rest of Europe
· APAC
o China
o Japan
o India
o South Korea
o Rest of APAC
· Rest of the World
Top Company Profiles
· Ypsomed AG
· BD
· Gerresheimer AG
· Halozyme, Inc.
· Haselmeier
· NuGen Medical Devices
· Owen Mumford Limited
· SHL Medical AG
· Pfizer Inc.
· Amgen Inc.
Related Posts
